Ma keʻano laulā, ʻaʻole maopopo ka huaʻai i loaʻa ka hopena "pōʻino" pololei i ka thrombosis.

Eia nō naʻe, ʻo ka lawe nui ʻana i kekahi mau huaora e loaʻa paha kekahi mau hopena maikaʻi ʻole i ke kino, kahi e hoʻopilikia pololei ʻole ai i nā mea pilikia o ka thrombosis. No ka laʻana, ʻo ka lawe nui ʻana i ka huaora E e hoʻopilikia i ka hana coagulation, hoʻonui i ka pilikia o ke kahe koko, a i kekahi mau hihia e hoʻopilikia paha i ka pale maʻamau o ke kino a me ke ʻano hoʻoponopono e kūʻē i ka thrombosis, akā hana pinepine kēia i ka wā e lawe ai i ka nui o ia mea no ka manawa lōʻihi ma mua o ka nui maʻamau.

Eia kekahi, ʻo ka wikamina K kahi wikamina e pili pono ana i ka coagulation, kahi e pili ana i ka synthesis o nā mea coagulation. Inā nele ka wikamina K, hiki ke alakaʻi i ka coagulation maʻamau a me ka hoʻonui ʻia o ka pilikia o ke kahe koko; akā inā lawe nui ʻia ka wikamina K, hiki ke hoʻokomo i ke koko i kahi kūlana hypercoagulable, kahi e hoʻonui ai i ka pilikia o ka thrombosis, akā ʻo kēia kūlana maʻamau e kū wale ana i nā hihia koʻikoʻi, e like me ka hoʻohana pono ʻole ʻana i nā dosis nui o nā hoʻomākaukau wikamina K.

Ma lalo o nā kūlana maʻamau, ʻo ka lawe ʻana i nā ʻano huaora like ʻole ma o ka ʻai kaulike maʻamau ʻaʻole ia he hopena maikaʻi ʻole i ka thrombosis. Ma ke ʻano ʻē aʻe, aia kekahi mau huaora e like me ka huaora C a me ka hui huaora B i kekahi mau pono i ka mālama ʻana i ke olakino vascular a me ka hoʻomaikaʻi ʻana i ke kahe koko, kahi e kōkua ai i ka hōʻemi ʻana i ka pilikia o ka thrombosis. Inā he mau maʻi a i ʻole nā ​​​​pilikia e pili ana i ka thrombosis, pono ʻoe e hahai i ka ʻōlelo aʻo a ke kauka no ka hoʻokele piha ʻana, me ka ʻai kūpono a me ka mālama ʻana i nā lāʻau lapaʻau e pono ai, ma mua o ka nānā wale ʻana i nā hopena o nā huaora i ka thrombosis.

ʻO Beijing Succeeder Technology Inc. (Stock code: 688338), i hoʻokumu ʻia i ka makahiki 2003 a ua helu ʻia mai ka makahiki 2020, he mea hana alakaʻi i nā diagnostics coagulation. He loea mākou i nā mea kālailai coagulation automated a me nā reagents, nā mea kālailai ESR/HCT, a me nā mea kālailai hemorheology. Ua hōʻoia ʻia kā mākou huahana ma lalo o ISO 13485 a me CE, a lawelawe mākou ma mua o 10,000 mau mea hoʻohana ma ka honua holoʻokoʻa.

Hoʻolauna ʻana o ka mea kālailai
Hiki ke hoʻohana ʻia ka mea loiloi Coagulation Automated Fully Automated SF-9200 (https://www.succeeder.com/fully-automated-coagulation-analyzer-sf-9200-product) no ka hoʻāʻo lapaʻau a me ka nānā mua ʻana. Hiki i nā haukapila a me nā mea noiʻi ʻepekema lapaʻau ke hoʻohana iā SF-9200. ʻO ia ka mea e hoʻohana ana i ka coagulation a me ka immunoturbidimetry, ke ʻano chromogenic e hoʻāʻo ai i ke kāpili ʻana o ka plasma. Hōʻike ka mea hana ʻo ka waiwai ana o ke kāpili ʻana ka manawa kāpili ʻana (i kekona). Inā hoʻoponopono ʻia ka mea hoʻāʻo e ka plasma calibration, hiki iā ia ke hōʻike i nā hopena pili ʻē aʻe.
Hana ʻia ka huahana me ka ʻāpana hoʻoneʻe probe laʻana, ka ʻāpana hoʻomaʻemaʻe, ka ʻāpana hoʻoneʻe cuvettes, ka ʻāpana hoʻomehana a me ka hoʻoluʻu ʻana, ka ʻāpana hoʻāʻo, ka ʻāpana hōʻike hana, ka interface LIS (hoʻohana ʻia no ka mea paʻi a me ka lā hoʻoili i ke kamepiula).
ʻO nā limahana loea a me nā mea kālailai akamai o ke kūlana kiʻekiʻe a me ka hoʻokele maikaʻi koʻikoʻi ka hōʻoia o ka hana ʻana o SF-9200 a me ka maikaʻi. Hoʻohiki mākou i kēlā me kēia mea hana i nānā ʻia a hoʻāʻo ʻia me ka paʻa. Kūlike ʻo SF-9200 i ke kūlana aupuni Kina, ke kūlana ʻoihana, ke kūlana ʻoihana a me ke kūlana IEC.